Hepatitis Annual Update 2017

Download slides and participate in videos from the live meetings that provide a comprehensive update on HCV management and new guidelines on HBV management.

Share

Program Content

Activities

HCV Treatment Options in 2017/2018
HCV Treatment Options in 2017/2018: What’s Here and What’s Coming Soon
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2017

Expires: June 15, 2018

Managing HCV DAA Failure
Managing HCV DAA Failure: Now and Later
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2017

Expires: June 15, 2018

Activities

Challenging Viral Hepatitis Cases
Challenging Patient Cases in HCV and HBV Infection
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 05, 2017

Expires: July 04, 2018

Initial HCV Therapy
Individualizing Initial HCV Therapy
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 12, 2017

Expires: July 11, 2018

Faculty

cover img faculity

Kristen Marks, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Weill Cornell Medicine
New York, New York

cover img faculity

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

cover img faculity

Norah Terrault, MD, MPH

Assistant Professor, Medicine and Surgery
Director of Viral Hepatitis Research, Liver Transplantation Program
University of California, San Francisco
San Francisco, California

cover img faculity

Tram T. Tran, MD

Medical Director of Liver Transplant
Comprehensive Transplant Center
Cedars Sinai Medical Center
Associate Professor of Medicine
Division of Gastroenterology
Geffen UCLA School of Medicine
Los Angeles, California

cover img faculity

David L. Wyles, MD

Associate Professor of Medicine
Division of Infectious Diseases
University of California, San Diego
La Jolla, California

Provided by

ProCE Banner

Supporters

Educational grants provided by

AbbVie

Bristol Myers Squibb

Gilead

Janssen

Merck & Co., Inc.

ViiV Healthcare